Insulinotropic action of monosaccharide esters: Therapeutic perspectives

Diabetologia

Volumn 42, Issue 3, 1999, Pages 286-291

  Malaisse, W J ^a  

^a FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

Insulin release; Monosaccharide esters

Indexed keywords

2 DEOXY BETA DEXTRO GLUCOSE TETRAACETIC ACID; ALPHA DEXTRO GALACTOSE PENTAACETIC ACID; ALPHA DEXTRO GLUCOSE PENTAACETIC ACID; ALPHA LEVO GLUCOSE PENTAACETIC ACID; ANTIDIABETIC AGENT; BETA DEXTRO GALACTOSE PENTAACETIC ACID; BETA DEXTRO GLUCOSE PENTAACETIC ACID; BETA LEVO GLUCOSE PENTAACETIC ACID; DEXTRO MANNOHEPTULOSE HEXAACETIC ACID; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; GUANIDINE DERIVATIVE; IMIDAZOLIDINE DERIVATIVE; INSULIN; LEUCINE; MEGLITINIDE; MONOSACCHARIDE; MONOSACCHARIDE ESTER; SUCCINIC ACID DIMETHYL ESTER; SULFONYLUREA DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONTROLLED STUDY; HYPERINSULINEMIA; INSULIN LIKE ACTIVITY; INSULINOMA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; RAT; REVIEW;

ANIMALS; DIABETES MELLITUS, TYPE 2; ESTERS; GLUCOSE; HUMANS; INSULIN; ISLETS OF LANGERHANS; MONOSACCHARIDES;

EID: 0032989875     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051152     Document Type: Review

References (81)

1. 1. Malaisse WJ (1998) Monosaccharide esters : new tools in biomedical research. Mol Gen Metab 65: 129-142
2. 2. Malaisse WJ, Jijakli H, Kadiata MM, Sener A, Kirk O (1997) Stimulation of insulin release by α-D-glucose pentaacetate. Biochem Biophys Res Commun 231: 213-214
3. 3. Sener A, Welsh N, Malaisse-Lagae F, Kadiata MM, Malaisse WJ (1998) Insulinotropic action of α-D-glucose pentaacetate : metabolic aspects. Mol Gen Metab 64: 135-147
4. 86Rb fluxes and membrane potential in pancreatic B-cell. Biochem Pharmacol 31: 1407-1415
5. 5. Meissner HP, Preissler M, Henquin JC (1980) Possible ionic mechanisms of the electrical activity induced by glucose and tolbutamide in pancreatic B-cells. In: Waldhäusl WK (ed) Diabetes. Excerpta Medica, Amsterdam, pp 166-171
6. 45Ca fluxes in microdissected pancreatic islets rich in B-cells. Mol Pharmacol 20: 83-88
7. 7. Hellman B, Sehlin J, Täljedal IB (1971) The pancreatic β-cell recognition of insulin secretagogues. II. Site of action of tolbutamide. Biochem Biophys Res Commun 45: 1384-1388
8. 8. Hellman B (1974) Factors affecting the uptake of glibenclamide in microdissected pancreatic islets rich in β-cells. Pharmacology 11: 257-267
9. 9. Kaubish N, Hammer R, Wollheim C, Renold AE, Offord RE (1982) Specific receptors for sulfonylureas in brain and in a β-cell tumor of the rat. Biochem Pharmacol 31: 1171-1174
10. 10. Deleers M, Malaisse WJ (1984) Binding of hypoglycaemic sulphonylureas to an artificial phospholipid bilayer. Diabetologia 26: 55-59
11. 11. Sehlin J (1973) Evidence for specific binding of tolbutamide to the plasma membrane of the pancreatic B-cells. Acta Diabetol 5: 1052-1060
12. 12. Täljedal IB (1974) Uptake of glibornuride by microdissected pancreatic islets. Horm Res 5: 211-216
13. 13. Hellman B, Sehlin J, Täljedal IB (1973) The pancreatic B-cell recognition of insulin secretagogues. IV. Islet uptake of sulphonylurea. Diabetologia 9: 210-216
14. 14. Loubatières A, Loubatières-Mariani MM (1974) Experimental study of the betacytotropic and betacytotrophic action of glisoxepide (Pro-Diaban). In: Schöffling K, Kroneberg G, Laudahn G (eds) Pro Diaban. F.K. Schattauer, Stuttgart, pp 53-63
15. 15. Gromada J, Dissing S, Kofod H, Frøkjaer-Jensen J (1995) Effects of the hypoglycaemic drugs repaglinide and glibenclamide on ATP-sensitive potassium-channels and cytosolic calcium levels in βTC3 cells and pancreatic beta cells. Diabetologia 38: 1025-1032
16. 16. Fuhlendorff J, Rorsman P, Kofod H et al. (1998) Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes. Diabetes 47: 345-351
17. 17. Ohnota H, Koizumi T, Tsutumi N, Kobayashi M, Inoue S, Sato F (1994) Novel rapid-and short-acting hypoglycemic agent, a calcium (2 S)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl)propionate (KAD-1229) that acts on the sulfonylurea receptor : comparison of effects between KAD-1229 and gliclazide. J Pharmacol Exp Ther 269: 489-495
18. 18. Shinkai H, Nashikawa M, Sato Y (1989) Separation of a new antidiabetic agent, N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanine, and its isomers by chiral high-performance liquid chromatography. J Liquid Chromatogr 12: 454-464
19. 19. Sato Y, Nishikawa M, Shinkai H, Sukegawa E (1991) Possibility of ideal blood glucose control by a new oral hypoglycemic agent, N-[(trans-4-isopropylcyclohexyl)-carbonyl]-D-phenylalanine (A4166), and its stimulatory effect on insulin secretion in animals. Diabetes Res Clin Pract 12: 53-60
20. 20. Kitahara Y, Akiyoshi M, Tsuchiya Y et al. (1998) Effect of A-4166 on postprandial hyperglycaemia in GK rats. Diabetologia 41[Suppl 1]A232
21. 21. Geisen K, Hübner M, Hitzel V et al. (1978) Acylaminoalkyl-substituierte Benzol-und Phenylalkansäuren mit blutglukosesenkender Wirkung. Arzneimittelforschung 28: 1081-1083
22. 3H-glibenclamide binding to sulfonylurea receptors by oral antidiabetics. Arzneimittelforschung 35: 707-712
23. 23. Puech R, Mantegheti M, Ribes G, Wollheim CB, Loubatières-Mariani MM (1985) Enhancement of insulin release and islet cell calcium content by an acyl-amino-alcyl benzoic derivative, HB 699. Horm Metab Res 17: 1-4
24. 24. Sakamoto Y, Morimoto S, Mokuda O (1998) AY-4166 increases the sensitivity of insulin secretion to glucose in isolated rat pancreas. Diabetologia 41[Suppl 1]A232
25. ATP channels and interaction with the exocytotic machinery. Diabetes 45: 1610-1618
26. 2+ mobilization from thapsigargin-sensitive stores in mouse pancreatic β-cells. Diabetes 47: 211-218
27. 27. Schulz A, Hasselblatt A (1989) An insulin-releasing property of imidazoline derivatives is not limited to compounds that block alphaadrenoceptors. Naunyn-Schmiedebergs Arch Pharmacol 340: 321-327
28. 28. Östenson CG, Cattaneo AG, Doxey JC, Efendic S (1989) Alphaadrenoceptors and insulin release from pancreatic islets of normal and diabetic rats. Am J Physiol 257: E439-E443
29. 2-sites. Br J Pharmacol 112: 1065-1070
30. + channels in pancreatic beta-cells. Br J Pharmacol 107: 8-14
31. ATP channels in insulin secreting cells. Eur J Pharmacol 204: 41-48
32. 32. Chan SLF, Morgan NG (1990) Stimulation of insulin secretion by efaroxan may involve interaction with potassium channels. Eur J Pharmacol 176: 97-101
33. 33. Byrom WD, Rotherman NE, Bratty JR (1994) Relationship between hypoglycaemic response and plasma concentrations of BTS 67 582 in healthy volunteers. Br J Clin Pharmacol 38: 433-439
34. 34. Dickinson K, North TJ, Sills S et al.(1997) BTS 67 582 stimulates insulin secretion from perifused rat pancreatic islets. Eur J Pharmacol 339: 69-76
35. 35. Jones RB, Dickinson K, Anthony DM, Marita AT, Kaul CL, Buckett WR (1997) Evaluation of BTS 67 582, a novel antidiabetic agent, in normal and diabetic rats. Br J Pharmacol 120: 1135-1143
36. 36. Skillman CA, Raskin P (1997) A double-masked placebo-controlled trial assessing effects of various doses of BTS 67 582, a novel insulinotropic agent, on fasting hyperglycemia in NIDDM patients. Diabetes Care 20: 591-596
37. 37. Göke R, Fehmann H-C, Göke B (1991) Glucagon-like peptide-1 (7-36)amide is a new incretin/enterogastrone candidate. Eur J Clin Invest 21: 135-144
38. 38. Fehmann H-C, Habener JF (1992) Insulinotropic glucagon-like peptide-I (7-37)/(7-36)amide. A new incretin hormone. Trends Endocrinol Metab 3: 158-163
39. 39. Ørskov C (1992) Glucagon-like peptide-1, a new hormone of the entero-insular axis. Diabetologia 35: 701-711
40. 40. Thorens B, Waeber G (1993) Glucagon-like peptide-I and the control of insulin secretion in the normal state and in NIDDM. Diabetes 42: 1219-1225
41. 41. Holst JJ (1994) Glucagonlike peptide 1 : a newly discovered gastro-intestinal hormone. Gastroenterology 107: 1848-1855
42. 42. Mojsov S, Weir GC, Habener JF (1987) Insulinotropin: glucagon-like peptide 1 (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J Clin Invest 79: 616-619
43. 43. Gutniak MK, Ørskov C, Holst JJ, Ahrén B, Efendic S (1992) Antidiabetogenic effect of glucagon-like peptide-1 (7-36) amide in normal subjects and patients with diabetes mellitus. New Engl J Med 326: 1316-1322
44. 44. Weir GC, Mojsov S, Hendrick GK, Habener JF (1989) Glucagon-like peptide-1 (7-37) actions on endocrine pancreas. Diabetes 38: 338-342
45. 45. Komatsu R, Matsuyama T, Namba M et al. (1989) Glucagonostatic and insulinotropic action of glucagonlike peptide 1-(7-36) amide. Diabetes 38: 902-905
46. 46. Göke R, Wagner B, Fehmann HC, Göke B (1993) Glucose-dependency of the insulin stimulatory effect of glucagonlike peptide-1 (7-36) amide on the rat pancreas. Res Exp Med (Berl) 193: 97-103
47. 47. Malaisse WJ, Sánchez-Soto C, Larrieta ME et al. (1997) Insulinotropic action of α-D-glucose pentaacetate : functional aspects. Am J Physiol 273: E1090-E1101
48. 48. Sener A, Kadiata MM, Olivares E, Malaisse WJ (1998) Comparison between the effects of D-mannoheptulose and its hexaacetate ester upon D-glucose metabolism and insulinotropic action in rat pancreatic islets. Diabetologia 41: 1109-1113
49. 49. Malaisse WJ, Flores LE, Kadiata MM (1998) Dual effect of 2-deoxy-D-glucose tetraacetate upon glucose-induced insulin release. Biochem Mol Biol Int 45: 429-434
50. 50. Malaisse WJ, Best LC, Herchuelz A et al. (1998) Insulinotropic action of β-L-glucose pentaacetate. Am J Physiol 275: E993-E1006
51. 51. Malaisse WJ, Malaisse-Lagae F (1997) Bitter taste of monosaccharide pentaacetate esters. Biochem Mol Biol Int 43: 1367-1371
52. 52. Malaisse WJ (1994) The beta-cell in non-insulin-dependent diabetes : giving light to the blind. Diabetologia 37[Suppl 2]S36-S42
53. 53. Malaisse WJ, Laghmich A, Ladrière L, Kadiata MM, Sener A (1998) Insulinotropic action of the polyacetate esters of metabolized and non-metabolized monosaccharides in pancreatic islets from normal and diabetic rats. Res Commun Mol Pathol Pharmacol 99: 81-92
54. 54. Malaisse WJ, Kadiata MM (1998) Insulinotropic action of the polyacetate esters of two non-nutrient monosaccharides in normal and diabetic rats. Int J Mol Med 2: 95-98
55. 55. Marynissen G, Leclercq-Meyer V, Sener A, Malaisse WJ (1990) Perturbation of pancreatic islet function in glucose-infused rats. Metabolism 39: 87-95
56. 56. Zhang T-M, Maggetto C, Malaisse WJ (1994) Hexose metabolism in pancreatic islets : glycogen synthase and glycogen phosphorylase activities. Biochem Med Metab Biol 51: 129-139
57. 57. Malaisse WJ, Marynissen G, Sener A (1992) Possible role of glycogen accumulation in B-cell glucotoxicity. Metabolism 41: 814-819
58. 58. Malaisse WJ, Maggetto C, Leclercq-Meyer V, Sener A (1993) Interference of glycogenolysis with glycolysis in pancreatic islets from glucose-infused rats. J Clin Invest 91: 432-436
59. 59. Gomis R, Novials A, Coves MJ, Casamitjana R, Malaisse WJ (1989) Suppression by insulin treatment of glucose-induced inhibition of insulin release in non-insulin-dependent diabetes. Diabetes Res Clin Pract 6: 191-198
60. 60. Bollen M, Malaisse-Lagae F, Malaisse WJ, Stalmans W (1990) The interaction of phosphorylase a with D-glucose displays α-stereospecificity. Biochim Biophys Acta 1038: 141-145
61. 61. Rovira A, Garrotte FJ, Valverde I, Malaisse WJ (1987) Anomeric specificity of glucose-induced insulin release in normal and diabetic subjects. Diabetes Res 5: 119-124
62. 62. Leclercq-Meyer V, Marchand J, Malaisse WJ (1987) Alteration of the insulin secretory response to D-glucose anomers in diabetic BB rats. Med Sci Res 15: 1535-1536
63. 63. Leclercq-Meyer V, Marchand J, Malaisse WJ (1987) Anomeric specificity of the insulin and glucagon secretory response to D-glucose in lean and obese Zucker rats. Pancreas 2: 645-652
64. 64. Leclercq-Meyer V, Marchand J, Malaisse WJ (1991) Attenuated anomeric difference of glucose-induced insulin release in the perfused pancreas of diazoxide-treated rats. Horm Metab Res 23: 257-261
65. 65. Fichaux F, Marchand J, Yaylali B, Leclercq-Meyer V, Catala J, Malaisse WJ (1991) Altered anomeric specificity of glucose-induced insulin release in rabbits with duct-ligated pancreas. Int J Pancreatol 8: 151-167
66. 66. Malaisse WJ (1991) The anomeric malaise : a manifestation of B-cell glucotoxicity. Horm Metab Res 23: 307-311
67. 67. West ES, Todd WR, Mason HS, Van Bruggen JT (1996) Textbook of Biochemistry, 4th edn. MacMillan, New York, p 211
68. 68. Malaisse WJ (1995) The esters of carboxylic nutrients as insulinotropic tools in non-insulin-dependent diabetes mellitus. Gen Pharmacol 26: 1133-1141
69. 69. Zhang T-M, Sener A, Malaisse WJ (1994) Metabolic effects and fate of succinic acid methyl esters in rat hepatocytes. Arch Biochem Biophys 314: 186-192
70. 70. García-Martínez JA, Cancelas J, Villanueva-Peñacarrillo ML, Valverde I, Malaisse WJ (1998) Insulinotropic action of β-L-glucose pentaacetate in vivo. Endocrinologia 45: 275
71. 71. Vanhoutte C, Sener A, Malaisse WJ (1998) Hydrolysis of hexose pentaacetate esters in rat pancreatic islets. Biochim Biophys Acta 1405: 78-84
72. 72. Kadiata MM, Malaisse WJ (1998) Opposite effects of D-glucose pentaacetate and D-galactose pentaacetate anomers on insulin release evoked by succinic acid dimethyl ester in rat pancreatic islets. Life Sci (in press)
73. 73. Malaisse WJ, Kadiata MM (1998) Inhibition of insulin release by α-and β-D-galactose pentaacetate. Int J Mol Med 2: 331-332
74. 74. García-Martínez JA, Ladrière L, Villanueva-Peñacarrillo ML, Valverde I, Malaisse WJ (1997) Insulinotropic action of α-D-glucose pentaacetate in vivo. Diabetes Nutr Metab 10: 198-202
75. 75. García-Martínez JA, Cancelas J, Villanueva-Peñacarrillo ML, Valverde I, Malaisse WJ (1998) In vivo stimulation of insulin release by 2-deoxy-D-glucose tetraacetate. Med Sci Res (in press)
76. 76. Malaisse WJ, Kadiata MM, Scruel O, Sener A (1998) Esterification of D-mannoheptulose confers to the heptose inhibitory action on D-glucose metabolism in parotid cells. Biochem Mol Biol Int 44: 625-633
77. 77. Vanhoutte C, Kadiata MM, Sener A, Malaisse WJ (1997) Potentiation by its esterification of the inhibitory action of 2-deoxy-D-glucose on D-glucose metabolism and insulinotropic action. Biochem Mol Biol Int 43: 189-195
78. 78. Malaisse WJ, Delvaux A, Rasschaert J, Kadiata MM (1998) Cytotoxic action of 2-deoxy-D-glucose tetraacetate in tumoral pancreatic islet cells. Cancer Lett 125: 45-49
79. 79. Delvaux A, Kadiata MM, Malaisse WJ (1997) Cytotoxicity of 2-deoxy-D-glucose and its tetraacetate ester in tumoral cell lines. Oncol Res 4: 1295-1299
80. 80. Reinhold U, Malaisse WJ (1998) Cytotoxic action of 2-deoxy-D-glucose tetraacetate upon human lymphocytes, fibroblasts and melanoma cells. Int J Mol Med 1: 427-430
81. 81. Malaisse WJ, Delvaux A (1997) Cytostatic effect of 2-deoxy-D-glucose and its tetraacetate ester in transformed mouse fibroblasts. Med Sci Res 25: 727-728